UBS Group
PDSB icon

UBS Group’s PDS Biotechnology PDSB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$722K Buy
543,021
+291,865
+116% +$388K ﹤0.01% 4579
2025
Q1
$299K Buy
251,156
+201,098
+402% +$239K ﹤0.01% 5027
2024
Q4
$81.6K Buy
50,058
+29,824
+147% +$48.6K ﹤0.01% 5781
2024
Q3
$77.3K Sell
20,234
-39,754
-66% -$152K ﹤0.01% 5345
2024
Q2
$176K Buy
59,988
+17,101
+40% +$50.1K ﹤0.01% 4637
2024
Q1
$170K Buy
42,887
+27,074
+171% +$107K ﹤0.01% 4813
2023
Q4
$78.6K Buy
15,813
+15,338
+3,229% +$76.2K ﹤0.01% 5120
2023
Q3
$2.4K Sell
475
-7,025
-94% -$35.5K ﹤0.01% 6565
2023
Q2
$37.7K Buy
7,500
+4,900
+188% +$24.6K ﹤0.01% 5551
2023
Q1
$16K Buy
+2,600
New +$16K ﹤0.01% 6163
2022
Q4
Sell
-9,883
Closed -$30K 9725
2022
Q3
$30K Buy
+9,883
New +$30K ﹤0.01% 5802
2022
Q2
Sell
-2,499
Closed -$15K 9589
2022
Q1
$15K Buy
+2,499
New +$15K ﹤0.01% 6792
2021
Q4
Sell
-2,946
Closed -$44K 9318
2021
Q3
$44K Buy
+2,946
New +$44K ﹤0.01% 5341
2021
Q1
Sell
-104,890
Closed -$224K 8139
2020
Q4
$224K Buy
104,890
+1,311
+1% +$2.8K ﹤0.01% 4209
2020
Q3
$241K Buy
+103,579
New +$241K ﹤0.01% 3882
2020
Q2
Sell
-38,400
Closed -$28K 7249
2020
Q1
$28K Buy
38,400
+32,950
+605% +$24K ﹤0.01% 5374
2019
Q4
$14K Buy
+5,450
New +$14K ﹤0.01% 6021
2019
Q3
Sell
-1,583
Closed -$9K 7116
2019
Q2
$9K Buy
+1,583
New +$9K ﹤0.01% 6258
2018
Q4
Sell
-30,897
Closed -$25K 7175
2018
Q3
$25K Sell
30,897
-12,709
-29% -$10.3K ﹤0.01% 5756
2018
Q2
$45K Buy
43,606
+23,606
+118% +$24.4K ﹤0.01% 5162
2018
Q1
$24K Buy
20,000
+19,098
+2,117% +$22.9K ﹤0.01% 5413
2017
Q4
$8K Buy
902
+237
+36% +$2.1K ﹤0.01% 6188
2017
Q3
$7K Buy
+665
New +$7K ﹤0.01% 6161
2017
Q2
Sell
-463
Closed -$4K 6801
2017
Q1
$4K Sell
463
-3,756
-89% -$32.4K ﹤0.01% 6147
2016
Q4
$52K Buy
4,219
+2,509
+147% +$30.9K ﹤0.01% 4889
2016
Q3
$18K Sell
1,710
-100
-6% -$1.05K ﹤0.01% 5484
2016
Q2
$18K Buy
+1,810
New +$18K ﹤0.01% 5504
2016
Q1
Sell
-1,713
Closed -$21K 6809
2015
Q4
$21K Buy
+1,713
New +$21K ﹤0.01% 5532